July 8, 2026 · Form 4 insider transaction
Metzger Michael A sold 32,375 shares of Syndax Pharmaceuticals, Inc. at $24.24 per share, a transaction worth $784.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 1,564,551 options to purchase shares of common stock that are vested and immediately exercisable and a total of 813,949 options to purchase shares of common stock that have not yet vested.; The sale prices ranged from $24.00 to $24.43